Real-Life Unmet NeedsReal-Life Unmet Needs

Real-Life Unmet Needs

Innovating from the Bedside to the Bench and Back

Real-Life Unmet NeedsReal-Life Unmet Needs

2nd slide

Innovating from the Bedside to the Bench and Back

Real-Life Unmet NeedsReal-Life Unmet Needs

3rd slide

Innovating from the Bedside to the Bench and Back

Spotlight Technologies

Preventing Pvr

A Novel Therapeutic Modality To Reduce Proliferative Retinopathy (Pvr)…

Arrow right

2nd slide

Preventing Pvr

A Novel Therapeutic Modality To Reduce Proliferative Retinopathy (Pvr)…

Arrow right

3rd slide

Preventing Pvr

A Novel Therapeutic Modality To Reduce Proliferative Retinopathy (Pvr). A Novel Therapeutic Modality To Reduce Proliferative Retinopathy (Pvr) A Novel Therapeutic Modality To Reduce Proliferative Retinopathy (Pvr)

Arrow right

Our Technologies

Medical Devices

Pharma

Diagnostics

Digital Health

Engineering And Logistics

View All Our Technologies

Inventor’s Guide

What Clalit Innovators Should Know

Got a brilliant idea that could solve an unmet patient need but don’t know where to begin? It may sound overwhelming, but we can make it happen.

Sharing Your Idea With Mor

Start By Contacting Us, So We Can Protect Your Idea And Lead You Down The Path To Future Commercialization.

Exploring Its Commercial Potential

We Will Perform An Initial Market Review To Determine The Feasibility And Viability Of Your Idea.

Writing The Patent

Patenting An Idea Is An Intricate Process With Multiple Technicalities That Affect Its Future Value.

Finding Early Funding

We Can Help You Identify Sources To Finance The Early Stages Of Your Work Through Grants And Special Funds.

Commercializing – Forging Ties With The Industry

We Will Look For The Right Partners And/Or Investors To Develop The Technology

Want to read all the details?

Latest News

Purple Biotech Inks Deal With Mor

The Pharma Letter

Purple Biotech Inks Deal With Mor…

Israel-based clinical-stage company Purple Biotech (Nasdaq: PPBT) saw its shares edge up more than 4% to 53.10 shekels today, when it announced

Arrow icon
Cathworks Announces First

Precision

Cathworks Announces First

CathWorks announced today that the first patient has been enrolled in the Advancing Cath

Arrow icon
Mediwound Announces

Mediwound

Mediwound Announces…

MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced positive data from its Phase I/II study to evaluate the safety and efficacy of MW005 in the treatment of low-risk Basal Cell Carcinoma (BCC). The data show MW005 to be safe and well-tolerated, with patients achieving complete clinical and histological clearance of their target lesions.

Arrow icon

About Us

Often, Healthcare Professionals Working Within The Clalit Health Services’ Wide Network Of Hospitals, Community Clinics, Diagnostic Facilities Or Labs Have The Opportunity To Identify Critical Unmet Needs And Come Up With Inventive Solutions That Can Help Patients, Attending Staff, And The System As A Whole.

Established In 1994, Mor Research Applications Is The End-To-End Technology Transfer Office Of Clalit Health Services. We Turn These Brilliant Ideas Into Viable Solutions In Medical Devices, Pharma, Diagnostics, Digital Healthcare, And Biotech, While Ensuring Their Inventors Enjoy The Fruit Of Their Hard Work And Ingenuity.

Read More
About us
Nutritional Growth Solutions
Zebra medical vision
EyeYon Medical
Exero medical
Cathworks
Neurophysiological AI

Our Success Stories

Ideas Born At Mor Bringing Relief Worldwide

We share some of the many stories we’re proud of having helped bring to fruition - from wild ideas to funded spinoff companies - all possible thanks to the ingenuity of our inventors, coupled with our expert support and guidance.

Our Spinoff Companies

We Transform Brilliant Ideas That Became Successful Businesses

Canfite BioPharma Ltd
MediWound
EyeYon Medical
endo.digital by dreamed
Explore All